Retinopathy is associated with cardiovascular and all-cause mortality in both diabetic and nondiabetic subjects: the hoorn study.

Diabetic retinopathy has been associated with increased cardiovascular and all-cause mortality risks among diabetic populations (1). The exact mechanism of this association, however, still remains unclear (1). Recently, we reported (2) that hypertension, dyslipidemia, and obesity are associated with retinopathy in diabetic and nondiabetic individuals. Conceivably, these associations with cardiovascular risk factors, which explain the occurrence of retinopathy in a nondiabetic population, may also explain the association of retinopathy and mortality. Therefore, the purpose of this population-based, prospective cohort study was to describe the association of …

[1]  T. Yoshikawa,et al.  Association between serum testosterone concentration and carotid atherosclerosis in men with type 2 diabetes. , 2003, Diabetes care.

[2]  G. Sesti,et al.  Weight loss in combination with physical activity improves endothelial dysfunction in human obesity. , 2003, Diabetes care.

[3]  O. Cohen,et al.  Effect of acute psychotic stress in nondiabetic subjects on beta-cell function and insulin sensitivity. , 2003, Diabetes care.

[4]  H. Chase,et al.  Modem transmission of glucose values reduces the costs and need for clinic visits. , 2003, Diabetes care.

[5]  M. Stumvoll,et al.  Adiponectin--its role in metabolism and beyond. , 2002, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[6]  L. Perlemuter,et al.  Feasibility and usefulness of dedicated software and e‐mail for self‐monitoring blood glucose in treating diabetes , 2002, Diabetic medicine : a journal of the British Diabetic Association.

[7]  L. Bouter,et al.  Blood pressure, lipids, and obesity are associated with retinopathy: the hoorn study. , 2002, Diabetes care.

[8]  R. Marfella,et al.  Reduction of Inflammatory Cytokine Concentrations and Improvement of Endothelial Functions in Obese Women After Weight Loss Over One Year , 2002, Circulation.

[9]  E. Barrett-Connor,et al.  Endogenous sex hormones and the development of type 2 diabetes in older men and women: the Rancho Bernardo study. , 2002, Diabetes care.

[10]  E. Pratt,et al.  Localized insulin allergy treated with continuous subcutaneous insulin , 2001, Diabetic medicine : a journal of the British Diabetic Association.

[11]  Torben Hansen,et al.  A P 387 L Variant in Protein Tyrosine Phosphatase-1 B ( PTP-1 B ) Is Associated With Type 2 Diabetes and Impaired Serine Phosphorylation of PTP-1 B In Vitro , 2001 .

[12]  J. Gern,et al.  Insulin desensitization with insulin lispro and an insulin pump in a 5-year-old child. , 2000, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[13]  Eary,et al.  CAROTID-ARTERY INTIMA AND MEDIA THICKNESS AS A RISK FACTOR FOR MYOCARDIAL INFARCTION AND STROKE IN OLDER ADULTS , 2000 .

[14]  R. Khardori,et al.  Lispro in the treatment of insulin allergy. , 1999, Diabetes care.

[15]  C. Bell,et al.  Genome scan for human obesity and linkage to markers in 20q13. , 1999, American journal of human genetics.

[16]  H. Chase,et al.  Use of insulin lispro in the outpatient management of ketonuria. , 1998, Archives of pediatrics & adolescent medicine.

[17]  V. Kamanna,et al.  Hyperlipidemia and kidney disease: concepts derived from histopathology and cell biology of the glomerulus. , 1998, Histology and histopathology.

[18]  P. Vallance,et al.  Inflammatory cytokines impair endothelium-dependent dilatation in human veins in vivo. , 1997, Circulation.

[19]  D. Kumar.  Lispro Analog for Treatment of Generalized Allergy to Human Insulin , 1997, Diabetes Care.

[20]  R. Marfella,et al.  L-arginine for testing endothelium-dependent vascular functions in health and disease. , 1997, The American journal of physiology.

[21]  H. Wedel,et al.  Lipoprotein abnormalities are associated with increased rate of progression of human chronic renal insufficiency. , 1997, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[22]  S. Haffner,et al.  Microalbuminuria and carotid artery intima-media thickness in nondiabetic and NIDDM subjects. The Insulin Resistance Atherosclerosis Study (IRAS). , 1997, Stroke.

[23]  H. Parving,et al.  Albuminuria and Poor Glycemic Control Predict Mortality in NIDDM , 1995, Diabetes.

[24]  J. Meyerovitch,et al.  Osmotic Loading of Neutralizing Antibodies Demonstrates a Role for Protein-tyrosine Phosphatase 1B in Negative Regulation of the Insulin Action Pathway (*) , 1995, The Journal of Biological Chemistry.

[25]  B. Fagerberg,et al.  Urinary albumin excretion is associated with the intima‐media thickness of the carotid artery in hypertensive males with non‐insulin‐dependent diabetes mellitus , 1995, Journal of hypertension.

[26]  R. Henry,et al.  Skeletal muscle protein tyrosine phosphatase activity and tyrosine phosphatase 1B protein content are associated with insulin action and resistance. , 1994, The Journal of clinical investigation.

[27]  J. Olefsky,et al.  Regulation of protein tyrosine phosphatases by insulin and insulin-like growth factor I. , 1993, The Journal of biological chemistry.

[28]  O. Samuelsson,et al.  Apolipoprotein-B-containing lipoproteins and the progression of renal insufficiency. , 1993, Nephron.

[29]  C. Bogardus,et al.  Abnormal Regulation of Protein Tyrosine Phosphatase Activities in Skeletal Muscle of Insulin-Resistant Humans , 1991, Diabetes.